Subacute-Onset Anemia Following COVID-19 Vaccine Combination with ChAdOx (AstraZeneca) and BNT162b2 (BioNTech, Pfizer)-A Case Report.

Comirnaty (tozinameran) - Pfizer, BioNTech

Vaxzevria (ChAdOx1-S recombinant) - University of Oxford, Emergent Biosolutions, Jenner Institute, Barinthus Bio, AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/42647298

Aristoteles Giagounidis; Konstantina Salveridou; Sabine Haase; Theodoros Tzamalis

Aug 27, 2026